We leverage our skills and excel in our ambitions through collaborative partnerships
At Zealand, we possess world-leading expertise in the design, optimization and development of novel peptide medicines. To optimize and leverage our competences, we engage with partners in many areas of our business; with academia, with biotech and pharma companies as well as with clinical centers, patient organizations and healthcare providers. It is the result of our core peptide expertise coupled with valuable partnerships that has led to our first invented medicine being on the market and created the foundation also for our broad-based pipeline of preclinical and clinical programs.
For selected products in our pipeline (proprietary programs) we are interested in new partnerships for co-development, partial out-licensing or co-investments.
We are also looking for peptide-based novel therapeutics which can compliment the current clinical and preclinical programs in our pipeline. We possess specific skills in the areas of cardio-metabolic diseases, inflammation and acute care, however, our peptide skills span a broader range of relevant therapeutic areas.
Further, we are interested in partnerships with technology-based companies. Finally, we are looking for partnerships also with providers of novel peptide structure enhancing or delivery technologies to help advance the profile of our peptide therapeutics.
Are you interested in a preclinical or clinical programs or do you have a partnership idea or technology opportunity that you want to share with us please contact us.
It is possible to meet representatives from Zealand at different events. Please click here.
“At Zealand, we are convinced that greater achievements require fruitful collaboration. Joining forces based on synergies/complementary skill sets will help us fulfill our goal – creating peptide medicines for people”.